Msh Capital Advisors LLC Bristol Myers Squibb CO Transaction History
Msh Capital Advisors LLC
- $323 Billion
- Q1 2025
A detailed history of Msh Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Msh Capital Advisors LLC holds 8,947 shares of BMY stock, worth $418,272. This represents 0.17% of its overall portfolio holdings.
Number of Shares
8,947
Previous 9,444
5.26%
Holding current value
$418,272
Previous $534 Million
2.16%
% of portfolio
0.17%
Previous 0.17%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,801Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.95 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.42 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.05 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.43 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.4B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...